General MedicationsORALGeneric
P.A.S. SODIUM
AMINOSALICYLATE SODIUM
Standard Dose
4GM/PACKET
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview P.A.S.
SODIUM is listed in Drugs@FDA under application 080947 (ANDA).
Structured Monograph
Clinical summary
Approval overview P.A.S. SODIUM is listed in Drugs@FDA under application 080947 (ANDA). Marketing status: Discontinued Active ingredient AMINOSALICYLATE SODIUM Form and strength POWDER;ORAL - 4GM/PACKET Sponsor CENTURY PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.